Arbutus Biopharma Corporation(ABUS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ABUS Arbutus Biopharma Corporation

盘后交易 05-07 18:03:06 EDT

4.35

-0.07

-1.58%

盘后4.43

+0.08+1.84%

17:56 EDT

最高4.45	最低4.28	成交量92.39万
今开4.41	昨收4.42	日振幅3.85%
总市值8.57亿	流通市值5.57亿	总股本1.97亿
成交额402.63万	换手率0.72%	流通股本1.28亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ABUS","market":"US","secType":"STK","nameCN":"Arbutus Biopharma Corporation","latestPrice":4.35,"timestamp":1778184000000,"preClose":4.42,"halted":0,"volume":923872,"hourTrading":{"tag":"盘后","latestPrice":4.43,"preClose":4.35,"latestTime":"17:56 EDT","volume":4334,"amount":18854.932646,"timestamp":1778191014382,"change":0.08,"changeRate":0.018391,"amplitude":0.01954},"delay":0,"changeRate":-0.015837104072398255,"floatShares":128000000,"shares":196939679,"eps":-0.174849,"marketStatus":"盘后交易","change":-0.07,"latestTime":"05-07 18:03:06 EDT","open":4.41,"high":4.445,"low":4.275,"amount":4026323.791584,"amplitude":0.038462,"askPrice":4.47,"askSize":100,"bidPrice":3.92,"bidSize":10100,"shortable":3,"etf":0,"ttmEps":-0.174849,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1778198400000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1184904000000,"exchange":"NASDAQ","adjPreClose":4.42,"preHourTrading":{"tag":"盘前","latestPrice":4.42,"preClose":4.42,"latestTime":"09:28 EDT","volume":7144,"amount":31000.549294400003,"timestamp":1778160493027,"change":0,"changeRate":0,"amplitude":0.022421},"postHourTrading":{"tag":"盘后","latestPrice":4.43,"preClose":4.35,"latestTime":"17:56 EDT","volume":4334,"amount":18854.932646,"timestamp":1778191014382,"change":0.08,"changeRate":0.018391,"amplitude":0.01954},"volumeRatio":1.125407,"impliedVol":0.5799,"impliedVolPercentile":0.3307},"requestUrl":"/m/hq/s/ABUS","defaultTab":"news","newsList":[{"id":"1153533743","title":"Arbutus旗下Imdusiran获美国FDA快速通道资格 用于治疗慢性乙型肝炎","url":"https://stock-news.laohu8.com/highlight/detail?id=1153533743","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153533743?lang=zh_cn&edition=full","pubTime":"2026-04-15 19:31","pubTimestamp":1776252689,"startTime":"0","endTime":"0","summary":"Arbutus Biopharma Corporation（股票代码：ABUS）宣布，其研发的乙肝治疗药物Imdusiran已获得美国食品药品监督管理局（FDA）授予的快速通道资格，将用于慢性乙型肝炎的治疗。\n这一重要监管里程碑有望加速该药物的审评进程，为患者提供更早获得创新疗法的可能。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ABUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115450583","title":"Roivant Sciences董事会批准10亿美元股票回购计划，包含2025年6月授权的5亿美元额度","url":"https://stock-news.laohu8.com/highlight/detail?id=1115450583","media":"美股速递","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1115450583?lang=zh_cn&edition=full","pubTime":"2026-03-04 05:17","pubTimestamp":1772572633,"startTime":"0","endTime":"0","summary":"Roivant Sciences Ltd. (ROIV) 宣布，其董事会已正式批准一项总额高达10亿美元的股票回购计划。值得注意的是，此项授权中包含了该公司在2025年6月已批准的5亿美元回购额度。\n这一大规模的回购举措彰显了管理层对公司未来前景的坚定信心，并反映了其致力于通过资本回报为股东创造价值的承诺。通过回购并注销股票，公司有望提升每股收益，从而优化股东权益。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ROIV","BK4139","ABUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121677386","title":"Roivant Sciences旗下Arbutus正评估于2026年第三季度向股东返还资本","url":"https://stock-news.laohu8.com/highlight/detail?id=1121677386","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1121677386?lang=zh_cn&edition=full","pubTime":"2026-03-04 05:17","pubTimestamp":1772572631,"startTime":"0","endTime":"0","summary":"Roivant Sciences Ltd. (ROIV) 旗下的生物制药公司 Arbutus Biopharma Corporation (ABUS) 目前正在积极评估一项资本返还计划。该计划旨在于2026日历年第三季度向公司股东返还资本。\n","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABUS","BK4139","BK4007","ROIV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133043250","title":"Arbutus Biopharma对欧洲专利局裁决结果提出异议 拟提请扩大申诉委员会复审","url":"https://stock-news.laohu8.com/highlight/detail?id=1133043250","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1133043250?lang=zh_cn&edition=full","pubTime":"2026-01-16 20:45","pubTimestamp":1768567541,"startTime":"0","endTime":"0","summary":"生物制药公司Arbutus Biopharma Corporation近日公开表示，其对于欧洲专利局（EPO）近期作出的专利裁决结果持不同意见。公司方面明确表态不接受该裁决结论，并已着手准备向EPO扩大申诉委员会提交复审请愿。这一法律行动彰显了Arbutus对其知识产权组合的坚定捍卫立场，也反映出生物医药领域专利争议的复杂性与重要性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ABUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124759487","title":"Arbutus Biopharma第三季度营收50万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1124759487","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1124759487?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:42","pubTimestamp":1763574141,"startTime":"0","endTime":"0","summary":"11月13日 - Arbutus Biopharma第三季度现金和投资为9370万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ABUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518207799","title":"Arbutus Biopharma Corporation盘中异动 下午盘股价大跌5.14%报3.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518207799","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518207799?lang=zh_cn&edition=full","pubTime":"2025-03-11 02:56","pubTimestamp":1741632962,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日02时56分，Arbutus Biopharma Corporation股票出现波动，股价快速下跌5.14%。截至发稿，该股报3.14美元/股，成交量62.6496万股，换手率0.33%，振幅5.56%。Arbutus Biopharma Corporation股票所在的生物技术行业中，整体涨幅为0.47%。其相关个股中，Mineralys Therapeutics, Inc.、Aeon Biopharma, Inc.、Checkpoint Therapeutics, Inc.涨幅较大，Aeon Biopharma, Inc.、Biodexa Pharmaceuticals Plc、Scisparc Ltd.较为活跃，换手率分别为6137.21%、3854.01%、1014.73%，振幅较大的相关个股有Aeon Biopharma, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Biodexa Pharmaceuticals Plc，振幅分别为90.44%、88.14%、59.34%。Arbutus Biopharma Corporation公司简介：Arbutus Biopharma Corp 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031102560398a2db22&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031102560398a2db22&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514354090","title":"Arbutus Biopharma Corporation盘中异动 早盘股价大涨8.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514354090","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514354090?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:31","pubTimestamp":1740493881,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时31分，Arbutus Biopharma Corporation股票出现异动，股价大幅上涨8.38%。截至发稿，该股报3.62美元/股，成交量3.106万股，换手率0.02%，振幅0.90%。Arbutus Biopharma Corporation股票所在的生物技术行业中，整体涨幅为0.36%。其相关个股中，Organovo Holdings, Inc.、Moleculin Biotech, Inc.、Silexion Therapeutics Corp涨幅较大，Gt Biopharma, Inc.、Organovo Holdings, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为746.68%、510.41%、459.93%，振幅较大的相关个股有Organovo Holdings, Inc.、Igm Biosciences, Inc.、Pluri Inc.，振幅分别为8.13%、7.46%、7.15%。Arbutus Biopharma Corporation公司简介：Arbutus Biopharma Corp 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223121a253866c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223121a253866c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABUS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509789216","title":"Arbutus Biopharma Corporation盘中异动 临近收盘大幅下挫5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509789216","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509789216?lang=zh_cn&edition=full","pubTime":"2025-02-07 04:56","pubTimestamp":1738875416,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日04时56分，Arbutus Biopharma Corporation股票出现异动，股价急速跳水5.01%。截至发稿，该股报3.41美元/股，成交量97.927万股，换手率0.52%，振幅5.43%。Arbutus Biopharma Corporation股票所在的生物技术行业中，整体跌幅为0.50%。其相关个股中，Lipella Pharmaceuticals Inc.、Geovax Labs Inc C/Wts 29/09/2025、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 涨幅较大，Lipella Pharmaceuticals Inc.、Transcode Therapeutics, Inc.、Ocean Biomedical, Inc.较为活跃，换手率分别为7126.59%、1780.58%、203.76%，振幅较大的相关个股有Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 ，振幅分别为125.58%、77.86%、65.64%。Arbutus Biopharma Corporation公司简介：Arbutus Biopharma Corp 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207045656a23c1b08&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207045656a23c1b08&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABUS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509510232","title":"Arbutus Biopharma Corporation盘中异动 急速拉升5.06%报3.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509510232","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509510232?lang=zh_cn&edition=full","pubTime":"2025-02-06 01:53","pubTimestamp":1738778039,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日01时53分，Arbutus Biopharma Corporation股票出现异动，股价大幅上涨5.06%。截至发稿，该股报3.53美元/股，成交量35.6686万股，换手率0.19%，振幅5.32%。Arbutus Biopharma Corporation股票所在的生物技术行业中，整体涨幅为1.97%。其相关个股中，Transcode Therapeutics, Inc.、Celularity Inc C/Wts 16/07/2026 、Pasithea Therapeutics Corp.涨幅较大，Pasithea Therapeutics Corp.、Transcode Therapeutics, Inc.、Oragenics Inc.较为活跃，换手率分别为4523.61%、2218.27%、1673.58%，振幅较大的相关个股有Oragenics Inc.、Transcode Therapeutics, Inc.、Pasithea Therapeutics Corp C/Wts 12/08/2026 ，振幅分别为122.81%、99.51%、59.58%。Arbutus Biopharma Corporation公司简介：Arbutus Biopharma Corp 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206015359987b9c9b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206015359987b9c9b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503215623","title":"Arbutus Biopharma Corporation盘中异动 早盘股价大涨5.03%报3.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503215623","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503215623?lang=zh_cn&edition=full","pubTime":"2025-01-15 23:21","pubTimestamp":1736954496,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日23时21分，Arbutus Biopharma Corporation股票出现波动，股价快速上涨5.03%。截至发稿，该股报3.34美元/股，成交量18.2586万股，换手率0.10%，振幅3.77%。Arbutus Biopharma Corporation股票所在的生物技术行业中，整体涨幅为1.27%。Arbutus Biopharma Corporation公司简介：Arbutus Biopharma Corp 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501152321369604c22f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501152321369604c22f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503686403","title":"Arbutus Biopharma Corporation盘中异动 快速下挫5.04%报3.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503686403","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503686403?lang=zh_cn&edition=full","pubTime":"2025-01-15 04:15","pubTimestamp":1736885701,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日04时15分，Arbutus Biopharma Corporation股票出现波动，股价急速下跌5.04%。截至发稿，该股报3.18美元/股，成交量46.9732万股，换手率0.25%，振幅5.82%。Arbutus Biopharma Corporation股票所在的生物技术行业中，整体跌幅为1.25%。其相关个股中，Eterna Therapeutics Inc.、Jasper Therapeutics Inc C/Wts 24/09/2026 、Xortx Therapeutics Inc.涨幅较大，Eterna Therapeutics Inc.、Phio Pharmaceuticals Corp.、Soligenix, Inc.较为活跃，换手率分别为1085.40%、604.84%、421.94%，振幅较大的相关个股有Eterna Therapeutics Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Matinas Biopharma Holdings, Inc.，振幅分别为170.74%、146.24%、69.81%。Arbutus Biopharma Corporation公司简介：Arbutus Biopharma Corp 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115041501abaaf625&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115041501abaaf625&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2502177405","title":"Arbutus Biopharma Corporation盘中异动 早盘股价大跌5.13%报3.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2502177405","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502177405?lang=zh_cn&edition=full","pubTime":"2025-01-09 00:03","pubTimestamp":1736352189,"startTime":"0","endTime":"0","summary":"北京时间2025年01月09日00时03分，Arbutus Biopharma Corporation股票出现波动，股价急速跳水5.13%。截至发稿，该股报3.24美元/股，成交量7.6845万股，换手率0.04%，振幅4.11%。Arbutus Biopharma Corporation股票所在的生物技术行业中，整体涨幅为0.38%。其相关个股中，Sana Biotechnology, Inc.、Silo Pharma, Inc.、Vir Biotechnology, Inc.涨幅较大，Silo Pharma, Inc.、60 Degrees Pharmaceuticals, Inc.、Nls Pharmaceutics Ltd.较为活跃，换手率分别为3131.05%、578.54%、556.13%，振幅较大的相关个股有Sana Biotechnology, Inc.、Silo Pharma, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ，振幅分别为192.73%、139.44%、88.32%。Arbutus Biopharma Corporation公司简介：Arbutus Biopharma Corp 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250109000309aba3605a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250109000309aba3605a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABUS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501771349","title":"杰富瑞：Arbutus(ABUS.US)将受益于大型制药公司的禽流感疫苗","url":"https://stock-news.laohu8.com/highlight/detail?id=2501771349","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501771349?lang=zh_cn&edition=full","pubTime":"2025-01-08 14:56","pubTimestamp":1736319369,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，杰富瑞认为，生物制药公司Arbutus Biopharma可能受益于Moderna和辉瑞/葛兰素史克/CureVac正在研发的H5N1禽流感疫苗。杰富瑞表示，Moderna，辉瑞及其合作伙伴BioNTech正被Arbutus起诉，称其在各自的新冠疫苗中使用的LNP技术侵犯了专利。杰富瑞补充称，如果这些制药公司在mRNA禽流感疫苗中使用与新冠疫苗相同的LNP成本，“特许权使用费可能会更高。”杰富瑞对Arbutus的股票评级为“买入”，目标价为7美元。截至周二美股收盘，Arbutus报每股3.41美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1234790.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK4127","BK1574","ABUS","01477","159646","JEF","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501780576","title":"Arbutus Biopharma Corporation盘中异动 股价大涨5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501780576","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501780576?lang=zh_cn&edition=full","pubTime":"2025-01-08 01:26","pubTimestamp":1736270779,"startTime":"0","endTime":"0","summary":"北京时间2025年01月08日01时26分，Arbutus Biopharma Corporation股票出现波动，股价快速拉升5.20%。截至发稿，该股报3.44美元/股，成交量62.0125万股，换手率0.33%，振幅5.66%。Arbutus Biopharma Corporation股票所在的生物技术行业中，整体涨幅为1.09%。其相关个股中，Hoth Therapeutics, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Conduit Pharmaceuticals Inc.涨幅较大，Hoth Therapeutics, Inc.、Cero Therapeutics Holdings, Inc.、Immuneering Corporation较为活跃，换手率分别为4925.63%、394.14%、236.23%，振幅较大的相关个股有Hoth Therapeutics, Inc.、Cero Therapeutics Holdings, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ，振幅分别为287.95%、131.21%、87.05%。Arbutus Biopharma Corporation公司简介：Arbutus Biopharma Corp 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108012620985e318a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108012620985e318a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2492589841","title":"Arbutus Biopharma Corporation盘中异动 股价大跌5.06%报3.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492589841","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492589841?lang=zh_cn&edition=full","pubTime":"2024-12-19 03:24","pubTimestamp":1734549849,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日03时24分，Arbutus Biopharma Corporation股票出现异动，股价快速跳水5.06%。截至发稿，该股报3.29美元/股，成交量38.9581万股，换手率0.21%，振幅4.91%。Arbutus Biopharma Corporation股票所在的生物技术行业中，整体跌幅为1.54%。其相关个股中，Polyrizon Ltd.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Cognition Therapeutics, Inc.涨幅较大，Polyrizon Ltd.、Cognition Therapeutics, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为3148.96%、647.96%、344.67%，振幅较大的相关个股有Polyrizon Ltd.、Cognition Therapeutics, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025，振幅分别为227.62%、127.32%、105.17%。Arbutus Biopharma Corporation公司简介：Arbutus Biopharma Corp 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121903240995ea58f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121903240995ea58f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2489311542","title":"Arbutus Biopharma Corporation盘中异动 急速拉升5.13%报3.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489311542","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489311542?lang=zh_cn&edition=full","pubTime":"2024-12-04 23:59","pubTimestamp":1733327958,"startTime":"0","endTime":"0","summary":"北京时间2024年12月04日23时59分，Arbutus Biopharma Corporation股票出现波动，股价大幅拉升5.13%。截至发稿，该股报3.59美元/股，成交量24.7831万股，换手率0.13%，振幅6.45%。Arbutus Biopharma Corporation股票所在的生物技术行业中，整体涨幅为0.03%。其相关个股中，Cyclerion Therapeutics, Inc.、Exicure, Inc.、Heron Therapeutics, Inc.涨幅较大，Cyclerion Therapeutics, Inc.、Can Fite Biopharma Ltd、Windtree Therapeutics, Inc.较为活跃，换手率分别为2953.25%、243.12%、127.51%，振幅较大的相关个股有Cyclerion Therapeutics, Inc.、Apollomics Inc C/Wts 01/04/2028 、Eterna Therapeutics Inc.，振幅分别为237.89%、61.32%、55.22%。Arbutus Biopharma Corporation公司简介：Arbutus Biopharma Corp 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120423591898e56125&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120423591898e56125&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABUS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2483306970","title":"Arbutus Biopharma Corporation盘中异动 早盘快速下跌5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483306970","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483306970?lang=zh_cn&edition=full","pubTime":"2024-11-16 00:01","pubTimestamp":1731686468,"startTime":"0","endTime":"0","summary":"北京时间2024年11月16日00时01分，Arbutus Biopharma Corporation股票出现异动，股价急速下挫5.23%。截至发稿，该股报3.44美元/股，成交量38.2825万股，换手率0.20%，振幅6.20%。Arbutus Biopharma Corporation股票所在的生物技术行业中，整体跌幅为3.47%。Arbutus Biopharma Corporation公司简介：Arbutus Biopharma Corp 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000110abc513dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000110abc513dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2483837423","title":"Arbutus Biopharma Corporation2024财年第三财季实现净利润-19.72百万美元，同比增加1.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483837423","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483837423?lang=zh_cn&edition=full","pubTime":"2024-11-15 00:01","pubTimestamp":1731600063,"startTime":"0","endTime":"0","summary":"11月15日，Arbutus Biopharma Corporation公布财报，公告显示公司2024财年第三财季净利润为-19.72百万美元，同比增加1.89%；其中营业收入为1.34百万美元，同比减少71.24%，每股基本收益为-0.10美元。从资产负债表来看，Arbutus Biopharma Corporation总负债33.55百万美元，其中短期债务468000.00美元，资产负债比为0.05，流动比率为0.08。机构评级：截至2024年11月15日，当前有5家机构对Arbutus Biopharma Corporation目标价做出预测，其中目标均价为5.10美元，其中最低目标价为4.00美元，最高目标价为7.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115000121a238002f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115000121a238002f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2481135474","title":"Arbutus Biopharma Corporation盘中异动 股价大跌5.10%报3.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481135474","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481135474?lang=zh_cn&edition=full","pubTime":"2024-11-08 00:59","pubTimestamp":1730998779,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日00时59分，Arbutus Biopharma Corporation股票出现波动，股价快速跳水5.10%。截至发稿，该股报3.72美元/股，成交量36.1723万股，换手率0.19%，振幅4.85%。Arbutus Biopharma Corporation股票所在的生物技术行业中，整体涨幅为0.48%。其相关个股中，Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Cingulate Inc C/Wts 10/12/2026 、Celularity Inc.涨幅较大，Ensysce Biosciences, Inc.、Elevai Labs, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为864.99%、385.85%、105.42%，振幅较大的相关个股有Celularity Inc.、180 Life Sciences Corp C/Wts 07/11/2025、Ensysce Biosciences, Inc.，振幅分别为84.83%、68.89%、57.79%。Arbutus Biopharma Corporation公司简介：Arbutus Biopharma Corp 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108005940a2213c52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108005940a2213c52&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2481986081","title":"Arbutus Biopharma Corporation盘中异动 急速跳水5.15%报3.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481986081","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481986081?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:32","pubTimestamp":1730903555,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时32分，Arbutus Biopharma Corporation股票出现异动，股价快速下挫5.15%。截至发稿，该股报3.76美元/股，成交量5.0993万股，换手率0.03%，振幅3.79%。Arbutus Biopharma Corporation股票所在的生物技术行业中，整体涨幅为0.49%。其相关个股中，Sonnet Biotherapeutics Holdings, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Sonnet Biotherapeutics Holdings, Inc.、Elevai Labs, Inc.、Zyversa Therapeutics, Inc.较为活跃，换手率分别为1070.77%、100.21%、52.15%，振幅较大的相关个股有Fate Therapeutics, Inc.、Nurix Therapeutics, Inc.、Inmed Pharmaceuticals Inc.，振幅分别为107.84%、106.06%、106.04%。Arbutus Biopharma Corporation公司简介：Arbutus Biopharma Corp 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223235971a4bf7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223235971a4bf7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABUS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.arbutusbio.com","stockEarnings":[{"period":"1week","weight":0.0702},{"period":"1month","weight":-0.009},{"period":"3month","weight":0.2044},{"period":"6month","weight":-0.0178},{"period":"1year","weight":0.3313},{"period":"ytd","weight":-0.0811}],"compareEarnings":[{"period":"1week","weight":0.0313},{"period":"1month","weight":0.1137},{"period":"3month","weight":0.083},{"period":"6month","weight":0.0937},{"period":"1year","weight":0.3132},{"period":"ytd","weight":0.0761}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Arbutus Biopharma Corporation于2005年10月6日在不列颠哥伦比亚省注册成立。该公司是一家临床阶段的生物制药公司，利用其广泛的病毒学专业知识来识别和开发具有独特作用机制的新疗法，这些疗法可以潜在地结合起来，为慢性乙型肝炎病毒（HBV）感染患者提供功能性治愈。公司内部开发的专有化合物管线包括一种RNA治疗药物imdusiran（AB-729）和一种口服PD-L1抑制剂AB-101。Imdusiran已经产生了有意义的临床数据，证明了对表面抗原减少和HBV特异性免疫反应的重新唤醒的影响。","yearOnYearQuotes":[{"month":1,"riseRate":0.454545,"avgChangeRate":-0.036052},{"month":2,"riseRate":0.818182,"avgChangeRate":0.072104},{"month":3,"riseRate":0.363636,"avgChangeRate":-0.053764},{"month":4,"riseRate":0.636364,"avgChangeRate":-0.004947},{"month":5,"riseRate":0.454545,"avgChangeRate":0.044554},{"month":6,"riseRate":0.5,"avgChangeRate":0.007771},{"month":7,"riseRate":0.5,"avgChangeRate":0.156856},{"month":8,"riseRate":0.4,"avgChangeRate":-0.016857},{"month":9,"riseRate":0.545455,"avgChangeRate":0.072042},{"month":10,"riseRate":0.181818,"avgChangeRate":-0.080232},{"month":11,"riseRate":0.545455,"avgChangeRate":0.037937},{"month":12,"riseRate":0.363636,"avgChangeRate":0.03682}],"exchange":"NASDAQ","name":"Arbutus Biopharma Corporation","nameEN":"Arbutus Biopharma"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Arbutus Biopharma Corporation(ABUS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Arbutus Biopharma Corporation(ABUS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Arbutus Biopharma Corporation,ABUS,Arbutus Biopharma Corporation股票,Arbutus Biopharma Corporation股票老虎,Arbutus Biopharma Corporation股票老虎国际,Arbutus Biopharma Corporation行情,Arbutus Biopharma Corporation股票行情,Arbutus Biopharma Corporation股价,Arbutus Biopharma Corporation股市,Arbutus Biopharma Corporation股票价格,Arbutus Biopharma Corporation股票交易,Arbutus Biopharma Corporation股票购买,Arbutus Biopharma Corporation股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Arbutus Biopharma Corporation(ABUS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Arbutus Biopharma Corporation(ABUS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}